A5087180043- Pharmaceutical Practices and Patient Outcomes
- Health Systems, Economic Evaluations, Quality of Life
- Medication Adherence and Compliance
- Chronic Disease Management Strategies
- Pharmaceutical studies and practices
- Balance, Gait, and Falls Prevention
- Blood Pressure and Hypertension Studies
- Pharmaceutical Economics and Policy
- Cardiac, Anesthesia and Surgical Outcomes
- Healthcare cost, quality, practices
- Mental Health Treatment and Access
- Vector-Borne Animal Diseases
- Agriculture and Farm Safety
- Antibiotic Use and Resistance
- Frailty in Older Adults
- Cardiac Health and Mental Health
- Public Health and Nutrition
- Opioid Use Disorder Treatment
- Treatment of Major Depression
- Schizophrenia research and treatment
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Delphi Technique in Research
- Musculoskeletal pain and rehabilitation
- Healthcare Systems and Public Health
- Patient Safety and Medication Errors
Edinburgh Napier University
2023-2024
Scottish Government
2016-2024
NHS Tayside
2015
British Medical Association
1972
Northern General Hospital
1972
University of Edinburgh
1972
Scottish Health Services
1972
University of Dundee
1972
Abstract Background Healthcare professionals are often reluctant to deprescribe fall-risk-increasing drugs (FRIDs). Lack of knowledge and skills form a significant barrier furthermore, there is no consensus on which medications considered as FRIDs despite several systematic reviews. To support clinicians in the management facilitate deprescribing process, STOPPFall (Screening Tool Older Persons Prescriptions older adults with high fall risk) tool were developed by European expert group....
In a survey of the farming population Orkney, Ayrshire, and East Lothian prevalence farmer's lung was estimated at 86 per 1,000 in both Orkney Ayrshire 23 Lothian. If cases with negative hay (F.L.H.) precipitin test are excluded these figures reduced to 43, 36, nil respectively, but those for still about 20 times higher than any figure previously reported Britain.Regional variations probably related climatic conditions differences agricultural methods, latter often being dictated by economic...
Clinical pharmacy as an area of practice, education and research started developing around the 1960s when pharmacists across globe gradually identified need to focus more on ensuring appropriate use medicines improve patient outcomes rather than being engaged in manufacturing supply. Since that time numerous studies have shown positive impact clinical services (CPS). The for wider adoption CPS worldwide becomes urgent, global population ages, prevalence polypharmacy well shortage healthcare...
Abstract Inappropriate polypharmacy is highly prevalent among older adults and presents a significant healthcare concern. Conducting medication reviews implementing deprescribing strategies in multimorbid with are an inherently complex challenging task. Recognizing this, the Special Interest Group on Pharmacology of European Geriatric Medicine Society has compiled evidence review formulated recommendations to enhance appropriate prescribing practices. The current supports need for...
Falls are a major public health concern in the older population, and certain medication classes significant risk factor for falls. However, knowledge is lacking among both physicians people, including caregivers, concerning role of as factor. In present statement, European Geriatric Medicine Society (EuGMS) Task Finish group on fall-risk-increasing drugs (FRIDs), collaboration with EuGMS Special Interest Pharmacology Union Medical Specialists (UEMS) Section, outlines its position regarding...
Introduction: Frailty is a distinctive health state related to the ageing process in which multiple body systems gradually lose their in-built reserves. A person living with frailty vulnerable significant, often sudden, changes and functional ability response what would usually be minor stressor event or change such as simple infection an alteration medication. They are more likely experience side-effects of medication shorter life expectancy limits time gain therapeutic benefit compared...
To provide an overview of the current deprescribing attitudes, practices, and approaches geriatricians geriatricians-in-training across Europe.An online survey was disseminated among European geriatricians-in-training. The comprised Likert scale multiple-choice questions on education knowledge, facilitators/barriers deprescribing. Responses to participant characteristics were quantified differences evaluated between regions.The 964 respondents (median age 42 years old; 64% female; 21%...
Background: Polypharmacy, defined as the simultaneous use of multiple medications by a patient, is worldwide problem rising prevalence. Paving way for drug interactions, adverse reactions and non-adherence, it leads to negative health outcomes, increased healthcare services costs. Since closely related multimorbidity, peaks in older adults. So far, not many polypharmacy management programs elderly have been introduced practice. However, due rapid ageing European societies, there an urgent...
Since 2012, NHS Scotland has published a series of polypharmacy guidelines to help clinicians address the many medication‐related problems arising from multimorbidity. Here, Alpana Mair, Chair guideline group, Martin Wilson and Tobias Dreischulte explain how third latest edition guidance been updated place greater emphasis on what matters patient.
A meeting organised by the Academy of Pharmaceutical Sciences focussed on challenges developing medicines for older adults. International experts discussed complexity introduced polypharmacy and multiple morbidities how risk–benefit ratio a medicine changes as an individual ages. The way in which regulatory authorities are encouraging development age-appropriate was highlighted. Examples were provided difficulties faced population with some medicinal products suggestions given to...
The annual amount spent on healthcare per capita is higher and expected to grow in the U.S. compared healthier level 4 countries (e.g., United Kingdom, Canada, Germany, Australia, Japan, Sweden, Netherlands), while health outcomes continue be suboptimal [1, 2, 3]. Therefore, slowly shifting from a fee-for-service value-based care, which addresses social determinants of health, promotes outcome-based contracting employs more Population Health Management (PHM) activities. root cause for this...
Purpose Polypharmacy, the concurrent use of multiple medicines by one individual, is a common and growing challenge driven an ageing population number people living longer with chronic conditions. Up to 11% unplanned hospital admissions in UK are attributable to, mostly avoidable, harm from medicines. However, this topic not yet central integrated practice. This paper reviews that polypharmacy presents health care system offers lessons for policy Design/methodology/approach Two commonly...